120 related articles for article (PubMed ID: 26609487)
1. NDUFA4 expression in clear cell renal cell carcinoma is predictive for cancer-specific survival.
Müller FE; Braun M; Syring I; Klümper N; Schmidt D; Perner S; Hauser S; Müller SC; Ellinger J
Am J Cancer Res; 2015; 5(9):2816-22. PubMed ID: 26609487
[TBL] [Abstract][Full Text] [Related]
2. NDUFA4 promotes cell proliferation by enhancing oxidative phosphorylation in pancreatic adenocarcinoma.
Zhang Y; Ge M; Chen Y; Yang Y; Chen W; Wu D; Cai H; Chen X; Wu X
J Bioenerg Biomembr; 2022 Dec; 54(5-6):283-291. PubMed ID: 36307669
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation in the NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 4 (
Yagil C; Varadi-Levi R; Yagil Y
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30361421
[TBL] [Abstract][Full Text] [Related]
4. A transgenic mouse expressing miR-210 in proximal tubule cells shows mitochondrial alteration: possible association of miR-210 with a shift in energy metabolism.
Nakada C; Hijiya N; Tsukamoto Y; Yano S; Kai T; Uchida T; Kimoto M; Takahashi M; Daa T; Matsuura K; Shin T; Mimata H; Moriyama M
J Pathol; 2020 May; 251(1):12-25. PubMed ID: 32073141
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of the suppression of proliferation and invasion ability mediated by microRNA-147b in esophageal squamous cell carcinoma].
Tang Y; Li Z; Shi ZX
Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(26):2092-2098. PubMed ID: 30032507
[No Abstract] [Full Text] [Related]
6. NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis.
Wang Z; Tao E; Chen Y; Wang Q; Liu M; Wei L; Xu S; Chen W; Zhong C
Biochem Cell Biol; 2023 Dec; 101(6):523-530. PubMed ID: 37602474
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Mammalian 13-Subunit Cytochrome c Oxidase and Binding of other Proteins: Role of NDUFA4.
Kadenbach B
Trends Endocrinol Metab; 2017 Nov; 28(11):761-770. PubMed ID: 28988874
[TBL] [Abstract][Full Text] [Related]
8. NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease.
Pitceathly RD; Rahman S; Wedatilake Y; Polke JM; Cirak S; Foley AR; Sailer A; Hurles ME; Stalker J; Hargreaves I; Woodward CE; Sweeney MG; Muntoni F; Houlden H; Taanman JW; Hanna MG;
Cell Rep; 2013 Jun; 3(6):1795-805. PubMed ID: 23746447
[TBL] [Abstract][Full Text] [Related]
9. NDUFA4 is a subunit of complex IV of the mammalian electron transport chain.
Balsa E; Marco R; Perales-Clemente E; Szklarczyk R; Calvo E; Landázuri MO; Enríquez JA
Cell Metab; 2012 Sep; 16(3):378-86. PubMed ID: 22902835
[TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
[TBL] [Abstract][Full Text] [Related]
11. Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
Stein J; Tenbrock J; Kristiansen G; Müller SC; Ellinger J
Int J Urol; 2019 Sep; 26(9):910-916. PubMed ID: 31280487
[TBL] [Abstract][Full Text] [Related]
12. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
Bismar TA; Bianco FJ; Zhang H; Li X; Sarkar FH; Sakr WA; Grignon DJ; Che M
Pathology; 2003 Dec; 35(6):513-7. PubMed ID: 14660102
[TBL] [Abstract][Full Text] [Related]
13. Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma.
Lin CS; Lee HT; Lee MH; Pan SC; Ke CY; Chiu AW; Wei YH
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231905
[TBL] [Abstract][Full Text] [Related]
14. Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.
Minton DR; Fu L; Mongan NP; Shevchuk MM; Nanus DM; Gudas LJ
Clin Cancer Res; 2016 Jun; 22(11):2791-801. PubMed ID: 26783287
[TBL] [Abstract][Full Text] [Related]
15. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
16. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract][Full Text] [Related]
17. NDUFA4 enhances neuron growth by triggering growth factors and inhibiting neuron apoptosis through Bcl-2 and cytochrome C mediated signaling pathway.
Fu F; Li Y; Li R; Lei TY; Wang D; Yang X; Han J; Pan M; Zhen L; Ou YM; Li J; Li FT; Jing XY; Li DZ; Liao C
Am J Transl Res; 2018; 10(1):164-174. PubMed ID: 29423002
[TBL] [Abstract][Full Text] [Related]
18. NDUFA4 (Renamed COXFA4) Is a Cytochrome-c Oxidase Subunit.
Pitceathly RDS; Taanman JW
Trends Endocrinol Metab; 2018 Jul; 29(7):452-454. PubMed ID: 29636225
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
20. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J
Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
